Our gain- and loss-of-function studies demonstrated that TET1 expression inhibits ovarian tumor growth and promotes apoptosis in vivo, while TET1 inhibition in tumor cells promotes tumor growth in vivo. The gene discussed is TET1; the disease is neoplasm.